Many employers get caught up in the promised savings offered by rebate guarantees… but little do they know this could actually be costing them money, for several reasons. The first issue with rebate guarantees is that the most significant rebates are… more »

The MedBen Rx approach to drug pricing is straightforward. We keep client costs low by reimbursing pharmacies what they pay for prescription drugs, plus a reasonable dispensing fee. By doing so, we ensure that self-funded employers get the maximum value… more »

In just four years, U.S. retail prescription drug spending grew nearly 27%... a substantial increase that illustrates the need for pharmacy solutions like those available through MedBen Rx. A new report from the Pew Charitable Trusts found that annual… more »

A recent Wall Street Journal editorial warns that government efforts to address prescription drug prices could produce undesirable consequences… and it's why MedBen Rx believes that market-driven solutions are the preferable method to reducing consumer… more »

New year, higher drug prices. According to The Wall Street Journal, a representative analysis of major pharmaceutical companies found that the prices of their brand name and generic drugs have risen by an average of 6.3% in 2019 – modest compared to… more »

Drug pricing can be a confusing business… and much of the confusion stems from a drug’s average wholesale price, or AWP. Simply defined, the AWP is the average price that a pharmacy or other retailer pays a wholesaler for a drug. But as straightforward… more »

Drug pricing transparency is currently a hot government topic: On October 10, President Trump signed two bills designed to end the drug industry's "gag order" of pharmacists, which prevent them from discussing cheaper price options with consumers.… more »